EBS
Companies
Nyse American
Emergent BioSolutions Inc.
Health Care
$6.78
-$2.78 (-29.08%)
Price Chart
Overview
About EBS
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Market Cap
$324.4M
Volume
10.2M
Avg. Volume
9.7M
P/E Ratio
1.506689
Dividend Yield
0.00%
Employees
2.1K
Company Information
Exchange
Nyse American
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Latest News for EBS
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
November 7, 2024
Health stocks jump as WHO declares mpox global health emergency
August 15, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz
August 30, 2024
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
May 29, 2025
Risk & Correlation Analysis
Market Correlation
2.45
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EBS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$324.4M
Volume10.2M
P/E Ratio1.51
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 4, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025